85 results
Page 2 of 5
6-K
EX-99.1
9a5wyvuq
3 Oct 22
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
6:02pm
6-K
EX-99.1
ptn8y6y
27 Sep 22
Current report (foreign)
5:03pm
6-K
EX-99.1
s7xn1ik1nsekpp3
30 Aug 22
Galapagos receives transparency notification from FMR LLC
6:00am
6-K
EX-99.1
2a1t9
24 Aug 22
Galapagos to present at upcoming investor conferences
4:48pm
6-K
EX-99.1
q70npw5 q8zzv06
19 Aug 22
Galapagos receives transparency notification from FMR LLC
8:43am
6-K
EX-99.1
wpysybuavo3q7l i6gng
9 Aug 22
Galapagos receives transparency notification from FMR LLC
6:20am
6-K
EX-99.2
zrrac kzjevy5pm0
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
3p2om7m i6kr
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
z1gyw9n2xjy4waonbj
31 May 22
Current report (foreign)
1:39pm
6-K
EX-99.1
wml j6wy6egq
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
zcs51 jk3
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.1
oy4nnp5tux6t
28 Mar 22
Jyseleca® approved in Japan for ulcerative colitis
1:50pm
6-K
EX-99.1
xuu01j 45oz
7 Feb 22
Current report (foreign)
2:40pm
6-K
EX-99.1
c9jwrf
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
ld7u6 n404
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.2
p89vi8a4t7lbdnjt0
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
rn8g5nyr0ctw103w u7
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
cqlhhekqfx
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
olceoei8
20 Sep 21
Current report (foreign)
9:26am